← Back to guidelines
Critical Care145 papers

Babesiosis

Last edited: 4/14/2026

Overview

Babesiosis is a tick-borne disease caused by protozoan parasites of the genus Babesia, primarily affecting dogs and humans. In dogs, Babesia canis is a common causative agent leading to severe hemolytic anemia and systemic complications 17.

Diagnosis

  • Clinical Signs: Hemolytic anemia, thrombocytopenia, fever, and nonspecific symptoms like respiratory distress 2.
  • Laboratory Tests:
  • - Hematology: Low platelet count, increased mean platelet volume, elevated percentage of large unstained cells 1. - Peripheral Smear: Identification of intraerythrocytic parasites or inclusion bodies 2. - PCR/Blood Smear: Confirmatory tests for Babesia DNA or direct visualization 1.
  • Biomarkers: Elevated levels of LTB4 and PGE2 in serum may indicate active disease 4.
  • Management

  • First-Line Treatments:
  • - Clindamycin: Often used in combination with [quinidine/quinine] 2.
  • Adjunctive Treatments:
  • - Red Cell Exchange Transfusion: For severe anemia 2. - Supportive Care: Fluid resuscitation, monitoring for organ dysfunction 25.

    Special Populations

  • Elderly: Susceptibility to severe complications including refractory shock and multiorgan failure 2.
  • Comorbidities: Presence of SIRS and MODS significantly impacts outcomes, with central nervous system and renal involvement correlating with higher mortality 5.
  • Key Recommendations

  • Utilize hematological parameters such as platelet count and large unstained cells for early screening of Babesia canis infection (Evidence: Moderate 1).
  • Initiate treatment with clindamycin, often combined with quinidine or quinine, for confirmed cases (Evidence: Expert opinion 2).
  • Monitor for and aggressively manage multiorgan dysfunction, particularly central nervous system and renal involvement, to improve outcomes (Evidence: Moderate 5).
  • References

    1 Pijnacker T, Bartels R, van Leeuwen M, Teske E. Identification of parameters and formulation of a statistical and machine learning model to identify Babesia canis infections in dogs using available ADVIA hematology analyzer data. Parasites & vectors 2022. link 2 Ripoll JG, Rizvi MS, King RL, Daniels CE. Severe . BMJ case reports 2018. link 3 Kuleš J, de Torre-Minguela C, Barić Rafaj R, Gotić J, Nižić P, Ceron JJ et al.. Plasma biomarkers of SIRS and MODS associated with canine babesiosis. Research in veterinary science 2016. link 4 Mrljak V, Kučer N, Kuleš J, Tvarijonaviciute A, Brkljačić M, Crnogaj M et al.. Serum concentrations of eicosanoids and lipids in dogs naturally infected with Babesia canis. Veterinary parasitology 2014. link 5 Welzl C, Leisewitz AL, Jacobson LS, Vaughan-Scott T, Myburgh E. Systemic inflammatory response syndrome and multiple-organ damage/dysfunction in complicated canine babesiosis. Journal of the South African Veterinary Association 2001. link 6 Passos LM, Bell-Sakyi L, Brown CG. Immunochemical characterization of in vitro culture-derived antigens of Babesia bovis and Babesia bigemina. Veterinary parasitology 1998. link00095-8) 7 Jacobson LS, Clark IA. The pathophysiology of canine babesiosis: new approaches to an old puzzle. Journal of the South African Veterinary Association 1994. link 8 Goodger BV, Commins MA, Waltisbuhl DJ, Wright IG, Rode-Bramanis K. Babesia bovis: immunity induced by vaccination with a lipid enriched fraction. International journal for parasitology 1990. link90129-b) 9 Moreau Y, Vidor E, Bissuel G, Dubreuil N. Vaccination against canine babesiosis: an overview of field observations. Transactions of the Royal Society of Tropical Medicine and Hygiene 1989. link90611-1) 10 Snary D, Smith MA. An antigenic determinant common to both mouse red blood cells and several membrane proteins of the parasitic protozoa Babesia rodhaini. Molecular and biochemical parasitology 1986. link90147-7)

    Original source

    1. [1]
    2. [2]
      Severe Ripoll JG, Rizvi MS, King RL, Daniels CE BMJ case reports (2018)
    3. [3]
      Plasma biomarkers of SIRS and MODS associated with canine babesiosis.Kuleš J, de Torre-Minguela C, Barić Rafaj R, Gotić J, Nižić P, Ceron JJ et al. Research in veterinary science (2016)
    4. [4]
      Serum concentrations of eicosanoids and lipids in dogs naturally infected with Babesia canis.Mrljak V, Kučer N, Kuleš J, Tvarijonaviciute A, Brkljačić M, Crnogaj M et al. Veterinary parasitology (2014)
    5. [5]
      Systemic inflammatory response syndrome and multiple-organ damage/dysfunction in complicated canine babesiosis.Welzl C, Leisewitz AL, Jacobson LS, Vaughan-Scott T, Myburgh E Journal of the South African Veterinary Association (2001)
    6. [6]
    7. [7]
      The pathophysiology of canine babesiosis: new approaches to an old puzzle.Jacobson LS, Clark IA Journal of the South African Veterinary Association (1994)
    8. [8]
      Babesia bovis: immunity induced by vaccination with a lipid enriched fraction.Goodger BV, Commins MA, Waltisbuhl DJ, Wright IG, Rode-Bramanis K International journal for parasitology (1990)
    9. [9]
      Vaccination against canine babesiosis: an overview of field observations.Moreau Y, Vidor E, Bissuel G, Dubreuil N Transactions of the Royal Society of Tropical Medicine and Hygiene (1989)
    10. [10]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG